Wall Street analysts expect AMERISAFE, Inc. (NASDAQ:AMSF) to post $92.63 million in sales for the current quarter, Zacks reports. Two analysts have made estimates for AMERISAFE’s earnings. The lowest sales estimate is $92.46 million and the highest is $92.80 million. AMERISAFE reported sales of $100.03 million during the same quarter last year, which would suggest a negative year-over-year growth rate of 7.4%. The company is expected to issue its next quarterly earnings report on Wednesday, February 28th.

According to Zacks, analysts expect that AMERISAFE will report full-year sales of $92.63 million for the current financial year, with estimates ranging from $373.00 million to $373.21 million. For the next financial year, analysts anticipate that the business will report sales of $364.25 million per share, with estimates ranging from $364.19 million to $364.30 million. Zacks’ sales averages are an average based on a survey of analysts that follow AMERISAFE.

AMERISAFE (NASDAQ:AMSF) last announced its earnings results on Wednesday, October 25th. The insurance provider reported $0.87 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.79 by $0.08. The company had revenue of $92.90 million during the quarter, compared to the consensus estimate of $92.04 million. AMERISAFE had a net margin of 17.07% and a return on equity of 13.92%. The firm’s revenue for the quarter was down 5.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.93 earnings per share.

AMSF has been the subject of several analyst reports. FBR & Co reiterated a “buy” rating on shares of AMERISAFE in a report on Wednesday, October 25th. B. Riley reiterated a “buy” rating on shares of AMERISAFE in a report on Monday, November 6th. SunTrust Banks reiterated a “buy” rating and issued a $69.00 target price on shares of AMERISAFE in a report on Friday, October 27th. Zacks Investment Research upgraded shares of AMERISAFE from a “hold” rating to a “buy” rating and set a $65.00 target price for the company in a report on Monday, September 18th. Finally, BidaskClub downgraded shares of AMERISAFE from a “buy” rating to a “hold” rating in a report on Wednesday, January 10th. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and an average target price of $66.00.

In related news, CEO G. Janelle Frost sold 1,728 shares of the firm’s stock in a transaction dated Tuesday, November 7th. The shares were sold at an average price of $66.74, for a total transaction of $115,326.72. Following the completion of the sale, the chief executive officer now owns 54,322 shares in the company, valued at $3,625,450.28. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 2.20% of the company’s stock.

A number of large investors have recently modified their holdings of the business. Nisa Investment Advisors LLC boosted its position in AMERISAFE by 186.0% during the fourth quarter. Nisa Investment Advisors LLC now owns 14,300 shares of the insurance provider’s stock worth $881,000 after purchasing an additional 9,300 shares during the period. Thomson Horstmann & Bryant Inc. boosted its position in AMERISAFE by 11.4% during the fourth quarter. Thomson Horstmann & Bryant Inc. now owns 15,391 shares of the insurance provider’s stock worth $948,000 after purchasing an additional 1,575 shares during the period. GSA Capital Partners LLP boosted its position in AMERISAFE by 166.6% during the third quarter. GSA Capital Partners LLP now owns 34,131 shares of the insurance provider’s stock worth $1,986,000 after purchasing an additional 21,331 shares during the period. Sterling Capital Management LLC boosted its position in shares of AMERISAFE by 15.8% in the third quarter. Sterling Capital Management LLC now owns 31,779 shares of the insurance provider’s stock valued at $1,850,000 after acquiring an additional 4,340 shares during the period. Finally, Wolverine Trading LLC bought a new position in shares of AMERISAFE in the third quarter valued at approximately $206,000.

Shares of AMERISAFE (NASDAQ:AMSF) traded down $0.45 during mid-day trading on Tuesday, hitting $60.60. 114,900 shares of the stock traded hands, compared to its average volume of 98,356. The stock has a market capitalization of $1,180.00, a P/E ratio of 18.04 and a beta of 0.88. AMERISAFE has a 52 week low of $51.20 and a 52 week high of $69.40.

The business also recently disclosed a quarterly dividend, which was paid on Thursday, December 28th. Investors of record on Thursday, December 14th were issued a dividend of $0.20 per share. The ex-dividend date was Wednesday, December 13th. This represents a $0.80 dividend on an annualized basis and a yield of 1.32%. AMERISAFE’s dividend payout ratio (DPR) is presently 23.81%.

WARNING: This piece of content was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of U.S. and international trademark and copyright legislation. The legal version of this piece of content can be accessed at https://www.thecerbatgem.com/2018/01/16/brokerages-expect-amerisafe-inc-amsf-will-announce-quarterly-sales-of-92-63-million.html.


Amerisafe, Inc is an insurance holding company. The Company is engaged in providing workers’ compensation insurance focused on small to mid-sized employers engaged in hazardous industries, principally construction, trucking, logging and lumber, manufacturing, and agriculture. It is engaged in underwriting the workers’ compensation exposures inherent in these industries.

Get a free copy of the Zacks research report on AMERISAFE (AMSF)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for AMERISAFE (NASDAQ:AMSF)

Receive News & Ratings for AMERISAFE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMERISAFE and related companies with MarketBeat.com's FREE daily email newsletter.